011170 — Lotte Chemical Balance Sheet
0.000.00%
- KR₩4tn
- KR₩16tn
- KR₩18tn
Annual balance sheet for Lotte Chemical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,493,886 | 3,717,405 | 3,886,904 | 3,338,889 | 2,562,199 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,946,109 | 2,862,414 | 2,764,305 | 2,321,260 | 2,018,281 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 9,430,723 | 9,466,180 | 9,814,400 | 8,983,402 | 7,994,481 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7,826,590 | 11,111,112 | 14,711,388 | 16,548,909 | 14,969,718 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 22,855,161 | 26,784,588 | 33,476,310 | 34,552,330 | 31,117,333 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,579,149 | 6,384,043 | 6,523,538 | 8,502,343 | 7,673,638 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,456,898 | 12,339,212 | 17,933,183 | 20,200,008 | 18,532,456 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 14,398,263 | 14,445,376 | 15,543,127 | 14,352,322 | 12,584,877 |
| Total Liabilities & Shareholders' Equity | 22,855,161 | 26,784,588 | 33,476,310 | 34,552,330 | 31,117,333 |
| Total Common Shares Outstanding |